<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M740</article-id>
      <article-id pub-id-type="publisher-id">molbank-2011-M740</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>N</italic>-(4-Methylsulfonamido-3-phenoxyphenyl)-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboximide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kankanala</surname>
            <given-names>Kavitha</given-names>
          </name>
          <xref rid="af1-molbank-2011-M740" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prakash</surname>
            <given-names>Varsha</given-names>
          </name>
          <xref rid="af2-molbank-2011-M740" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mukkanti</surname>
            <given-names>Khagga</given-names>
          </name>
          <xref rid="af2-molbank-2011-M740" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reddy</surname>
            <given-names>Vangala Ranga</given-names>
          </name>
          <xref rid="af3-molbank-2011-M740" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pal</surname>
            <given-names>Sarbani</given-names>
          </name>
          <xref rid="af1-molbank-2011-M740" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2011-M740" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2011-M740"><label>1</label>MNR Degree &amp; PG College, Kukatpally, Hyderabad-500085, A. P., India</aff>
      <aff id="af2-molbank-2011-M740"><label>2</label>Centre for chemical Sciences and Technology, Institute of Science &amp; Technology, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad-500085, A. P., India</aff>
      <aff id="af3-molbank-2011-M740"><label>3</label>Dr. Reddy&#x2019;s Laboratories Ltd., IPDO, Bachupally, Hyderabad-500085, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2011-M740"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>Sarbani277@yahoo.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <volume>2011</volume>
      <issue>4</issue>
      <elocation-id>M740</elocation-id>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>09</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>09</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound, <italic>N</italic>-(4-methylsulfonamido-3-phenoxyphenyl)-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboximide was synthesized in high yield by reaction of <italic>N</italic>-(4-amino-2-phenoxyphenyl)methanesulfonamide and 9,10-dihydroanthracene-9,10-endo-&#x3B1;,&#x3B2;-succinic anhydride in glacial acetic acid. The structure of the compound was fully characterized by IR, <sup>1</sup>H and <sup>13</sup>C NMR, mass spectral analysis and elemental analysis.</p>
      </abstract>
      <kwd-group>
        <kwd>sulfonamide</kwd>
        <kwd>cyclic imide</kwd>
        <kwd>nimesulide</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Cyclic imides <bold>A</bold> (<bold><xref ref-type="scheme" rid="molbank-2011-M740-sch001">Scheme 1</xref></bold>) represent an important class of bioactive molecules that shows a wide range of pharmacological activities such as androgen receptor antagonistic, anti-inflammatory, anxiolytic, antiviral, antibacterial, antitumor, antispasmodic, antinociceptive and antineoplastic properties [<xref ref-type="bibr" rid="B1-molbank-2011-M740">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2011-M740">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2011-M740">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2011-M740">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2011-M740">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2011-M740">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2011-M740">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2011-M740">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2011-M740">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2011-M740">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2011-M740">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2011-M740">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2011-M740">13</xref>]. </p>
      <p>On the other hand <italic>N</italic>-(4-nitro-2-phenoxy phenyl)methane sulfonamide or nimesulide (<bold>B</bold>, <bold><xref ref-type="scheme" rid="molbank-2011-M740-sch001">Scheme 1</xref></bold>), a preferential cyclooxygenase-2 (COX-2) inhibitor is one of the well known non-steroidal anti-inflammatory drugs (NSAIDs) that has been utilized to treat pain and other inflammatory diseases. Because of their common anti-inflammatory properties and our interest in nimesulide (<italic>N</italic>-(4-nitro-2-phenoxy phenyl)methane sulfonamide) derivatives [<xref ref-type="bibr" rid="B14-molbank-2011-M740">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2011-M740">15</xref>,<xref ref-type="bibr" rid="B16-molbank-2011-M740">16</xref>,<xref ref-type="bibr" rid="B17-molbank-2011-M740">17</xref>,<xref ref-type="bibr" rid="B18-molbank-2011-M740">18</xref>] as potential anti-inflammatory agents we decided to prepare compound <bold>C</bold> having structural features of both <bold>A</bold> and <bold>B </bold>(<bold><xref ref-type="scheme" rid="molbank-2011-M740-sch001">Scheme 1</xref></bold>).</p>
      <p>We estimated that combination of structural features of cyclic imide (<bold>A</bold>) with nimesulide (<bold>B)</bold> in a single molecule (<bold>C</bold>) would provide novel agents possessing potent pharmacological activities. </p>
      <p>We report the synthesis<italic> N</italic>-(4-methylsulfonamido-3-phenoxyphenyl)-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboximide (<bold>3</bold>) as hybrid molecule derived from <italic>N</italic>-(4-nitro-2-phenoxy phenyl)methane sulfonamide, <bold>B</bold>, nimesulide by straight forward condensation of the key intermediate <italic>N</italic>-(4-amino-2-phenoxy-phenyl)-methane sulfonamide (<bold>1</bold>) and 9,10-dihydro anthracene -9,10-endo-&#x3B1;,&#x3B2;-succinic anhydride (<bold>2</bold>).</p>
      <p>The starting compound <bold>1</bold> (<italic>N</italic>-(4-amino-2-phenoxy-phenyl)-methane sulfonamide) required for our study was prepared [<xref ref-type="bibr" rid="B14-molbank-2011-M740">14</xref>] in quantitative yield from <italic>N</italic>-(4-nitro-2-phenoxy phenyl)methane sulfonamide <bold>B</bold>, (nimesulide) <italic>via</italic> reducing its nitro group as shown in <bold><xref ref-type="scheme" rid="molbank-2011-M740-sch002">Scheme 2</xref></bold>. </p>
      <p>To a mixture of aromatic amine, (<italic>N</italic>-(4-amino-2-phenoxy-phenyl)-methane sulfonamide) <bold>1</bold> (278 mg, 1.0 mmol) and 9,10-dihydroanthracene 9,10-endo-&#x3B1;,&#x3B2;-succinic anhydride (<bold>2</bold>) (276 mg, 1.0 mmol) in glacial acetic acid (3 mL) was added anhydrous sodium acetate (100 mg, 1.2 mmol) and the mixture was allowed to reflux for 20 min. After completion of the reaction (as indicated by TLC) the mixture was added to crushed ice (50 g) and stirred. The solid separated was filtered and dried. The crude product was purified by column chromatography followed by re-crystallization from chloroform.</p>
      <p>Description of the compound: White solid.</p>
      <p>Yield: 84%.</p>
      <p>Mp: 309&#x2013;311 &#xB0;C.</p>
      <p>R<sub>f</sub>: 0.59 (CHCl<sub>3</sub>:Ethyl acetate = 9:1).</p>
      <p>IR &#x3C5;<sub>max</sub> (KBr cm<sup>&#x2212;1</sup>): 3155, 1705, 1502, 1331, 1157. </p>
      <p>Mass (ES): m/z 538 (M+1, 100%).</p>
      <p><sup>1</sup>HNMR (400 MHz, DMSO-<italic>d<sub>6</sub></italic>): &#x3B4; 3.0 (s, 3H), 3.31(s, 2H), 4.81(s, 2H), 5.87(d, <italic>J</italic> 2.2 Hz, 1H), 6.29 (dd, <italic>J</italic> 8.6 and 2.2 Hz, 1H), 6.86 (dd, <italic>J</italic> 5.2 and 3.3 Hz, 2H), 7. 0 (d, <italic>J</italic> 7.6 Hz, 2H), 7.14&#x2013;7.18 (m, 4H), 7.27&#x2013;7.29 (m, 1H), 7.35 (d. <italic>J</italic> 8.5Hz, 1H), 7.46&#x2013;7.50 (m, 4H), 9.35 (1H, NH).</p>
      <p><sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): &#x3B4; 30.9 (CH<sub>3</sub>), 39.8, 45.9, 47.02, 115.6, 119.4, 120.6, 122.1, 124.3 124.9, 126.9, 127.0, 128.1, 128.2, 130.3, 138.5, 141.0, 147.2, 155.0, 175.8 (CO). </p>
      <p>Anal. calc. for C<sub>31</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub>S: C, 69.39; H, 4.51; N, 5.22 . Found: C, 69.28; H, 4.46; N, 5.28.</p>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2011-M740">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2011-M740-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M740-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2011-M740-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M740-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
<supplementary-material id="molbank-2011-M740-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M740-s002.docx">
   <label>Supplementary File 3</label>
</supplementary-material>
</app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors (S. Pal and K. Kavitha) thank Mr. M. N. Raju, the chairman of M. N. R. Educational Trust for his constant encouragement.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2011-M740">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salvati</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Balog</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Pickering</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Attar</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Geng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rizzo</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Gottardis</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Weinmann</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Krystek</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Sack</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kish</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>271</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.10.085</pub-id>
          <pub-id pub-id-type="pmid">15603938</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2011-M740">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sondhi</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Rani</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Microwave-Assisted Synthesis of N-Substituted Cyclic Imides and Their Evaluation for Anticancer and Antiinflammatory Activities</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>1534</fpage>
          <lpage>1538</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.07.048</pub-id>
          <pub-id pub-id-type="pmid">19201604</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2011-M740">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishizumi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Antoku</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3-bicyclo[2.2.1] heptanedicarboximide (tandospirone) and related compounds</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>1991</year>
          <volume>39</volume>
          <fpage>2288</fpage>
          <lpage>2300</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.39.2288</pub-id>
          <pub-id pub-id-type="pmid">1687114</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2011-M740">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibata</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shiehita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Iwasaki</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>N-Alkylphthalimides: Structural requirement of thalidomidal action on 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor alpha production by human leukemia HL-60 cells</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>1995</year>
          <volume>43</volume>
          <fpage>177</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.43.177</pub-id>
          <pub-id pub-id-type="pmid">7895307</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2011-M740">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jindal</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Bedi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Jit</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Karkra</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Guleria</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Palusczak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hartmann</surname>
              <given-names>R.W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents</article-title>
          <source>Il Farmaco</source>
          <year>2005</year>
          <volume>60</volume>
          <fpage>283</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1016/j.farmac.2005.01.011</pub-id>
          <pub-id pub-id-type="pmid">15848202</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2011-M740">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Chern</surname>
              <given-names>Y.T.</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> antitumor and antimicrobial activities of N-substituents of maleimide by adamantane and diamantane</article-title>
          <source>Chemotherapy</source>
          <year>1997</year>
          <volume>43</volume>
          <fpage>182</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="doi">10.1159/000239557</pub-id>
          <pub-id pub-id-type="pmid">9142459</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2011-M740">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machado</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Arau&#xB4;jo</surname>
              <given-names>J.X.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Fraga</surname>
              <given-names>C.A.M.</given-names>
            </name>
            <name>
              <surname>Koatz</surname>
              <given-names>V.L.G.</given-names>
            </name>
            <name>
              <surname>Barreiro</surname>
              <given-names>E.J.I.</given-names>
            </name>
          </person-group>
          <article-title>Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>1169</fpage>
          <lpage>1172</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.12.012</pub-id>
          <pub-id pub-id-type="pmid">15686935</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2011-M740">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenji</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hideko</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yoshihiro</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Yoshikazu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kazuharu</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Motoji</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Konstanty</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Tadafumi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tetsuji</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yuji</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kenji</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hitoshi</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Napthalimidobenzamide DB-51630: A novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>4014</fpage>
          <lpage>4021</lpage>
        </citation>
      </ref>
      <ref id="B9-molbank-2011-M740">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Neuenhofer</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Luminescent labels - more than just an alternative to radioisotopes</article-title>
          <source>Angew. Chem. Int. Ed.</source>
          <year>1994</year>
          <volume>33</volume>
          <fpage>1044</fpage>
          <lpage>1072</lpage>
          <pub-id pub-id-type="doi">10.1002/anie.199410441</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2011-M740">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miguel</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Gema</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Beatriz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cynthia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Simmon</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Teresa</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antitumour activity of new dendritic polyamines&#x2013;(imide&#x2013;DNA-intercalator) conjugates: potent Lck inhibitors</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>541</fpage>
          <lpage>551</lpage>
        </citation>
      </ref>
      <ref id="B11-molbank-2011-M740">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyachi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ogasawara</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Uchimura</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Novel biological response modifiers: Phthalimides with tumor necrosis factor-alpha production-regulating activity</article-title>
          <source>J. Med. Chem.</source>
          <year>1997</year>
          <volume>40</volume>
          <fpage>2858</fpage>
          <lpage>2865</lpage>
          <pub-id pub-id-type="doi">10.1021/jm970109q</pub-id>
          <pub-id pub-id-type="pmid">9288167</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2011-M740">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mederski</surname>
              <given-names>W.W.K.R.</given-names>
            </name>
            <name>
              <surname>Baumgarth</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Germann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kux</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Weitzel</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>A Convenient Synthesis of 4-Aminoaryl Substituted Cyclic Imides</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>2133</fpage>
          <lpage>2136</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(03)00167-9</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2011-M740">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cremlyn</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Swinbourne</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Diels Alder Reactions using N-(p-Chlorosulfonyl)-Maleimide a dienophile</article-title>
          <source>Phosphorous Sulfur Relat. Elem.</source>
          <year>1987</year>
          <volume>33</volume>
          <fpage>65</fpage>
          <pub-id pub-id-type="doi">10.1080/03086648708074284</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2011-M740">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pericherla</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mareddy</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rani</surname>
              <given-names>D.P.G.</given-names>
            </name>
            <name>
              <surname>Gollapudi</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Chemical Modifications of Nimesulide</article-title>
          <source>J. Braz. Chem. Soc.</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>384</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="doi">10.1590/S0103-50532007000200021</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2011-M740">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>L.V.</given-names>
            </name>
            <name>
              <surname>Nakka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Suman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Helliwell</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mukkanti</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
		  <article-title>Synthesis of Novel Quinoline Analogues of Nimesulide: An Unusual Observation</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2011</year>
          <volume>48</volume>
          <fpage>555</fpage>
          <lpage>562</lpage>
        </citation>
      </ref>
      <ref id="B16-molbank-2011-M740">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durgadas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chatare</surname>
              <given-names>V.K.</given-names>
            </name>
            <name>
              <surname>Mukkanti</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Palladium-mediated synthesis of novel nimesulide derivatives</article-title>
          <source>Appl. Organomet. Chem.</source>
          <year>2010</year>
          <volume>24</volume>
          <fpage>680</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="doi">10.1002/aoc.1666</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2011-M740">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kankanala</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>V.R.</given-names>
            </name>
            <name>
              <surname>Mukkanti</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Lewis Acid Free High Speed Synthesis of Nimesulide-Based Novel <italic>N</italic>-Substituted Cyclic Imides</article-title>
          <source>J. Braz. Chem. Soc.</source>
          <year>2010</year>
          <volume>21</volume>
          <fpage>1060</fpage>
          <lpage>1064</lpage>
          <pub-id pub-id-type="doi">10.1590/S0103-50532010000600015</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2011-M740">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>L.V.</given-names>
            </name>
            <name>
              <surname>Kethavath</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Beevi</surname>
              <given-names>S.S.</given-names>
            </name>
			<name>
              <surname>Mangamoori</surname>
              <given-names>L.N.</given-names>
            </name>
			<name>
              <surname>Mukkanti</surname>
              <given-names>K.</given-names>
            </name>
			<name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Design and Synthesis of Novel Cytotoxic Agents Based on Combined Framework of Quinoline and Nimesulide</article-title>
          <source>J. Heterocycl. Chem.</source>
          <fpage>2011</fpage>
          <pub-id pub-id-type="doi">10.1002/jhet.801</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Schemes</title>
      <fig id="molbank-2011-M740-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2011-M740-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Design of hybrid molecule.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M740-sch001.tif"/>
      </fig>
      <fig id="molbank-2011-M740-sch002" position="float">
        <object-id pub-id-type="pii">molbank-2011-M740-sch002_Scheme 2</object-id>
        <label>Scheme 2</label>
        <caption>
          <p>Synthesis of the title compound <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M740-sch002.tif"/>
      </fig>
    </sec>
  </back>
</article>
